ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Conjugate

Also written as “Adsorbed Acellular Pertussis (3-Component) Diphtheria-Tetanus-Pertussis-Haemophilus influenzae type b (Conjugate)-Meningococcal Group ACYW135 (Conjugate) Combined Vaccine (DTcP-Hib-MCV4)” and “Meningococcal Group ACYW135 (Conjugate) (MCV4)”.

Its studies are mostly in Diphtheria, led by CanSino Biologics.

Furthest: phase 1, since Sep 25, 20251 company-led study, 1 open or runningNext primary completion: Feb 2029 (phase 1)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
CanSino Biologics11 open or runningphase 1since Sep 25, 2025Sep 25, 2025Feb 2029phase 1 · NCT07203755

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). An open circle marks the day WHO proposed its name. Dates ahead are the sponsors’ estimates.

  1. Feb 29, 2024Named conjugateINNProposed as its International Nonproprietary Name in WHO's List 130
  2. Sep 25, 2025First study: phase 1 study in DiphtheriaFirst studyNCT07203755 · 260 planned · China

Ahead

  1. Feb 2029Primary completion: phase 1 study in DiphtheriaNCT07203755

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 1 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07203755Diphtheria · China1RecruitingFeb 2029260

How it is read

Names in the registry

  • “Adsorbed Acellular Pertussis (3-Component) Diphtheria-Tetanus-Pertussis-Haemophilus influenzae type b (Conjugate)-Meningococcal Group ACYW135 (Conjugate) Combined Vaccine (DTcP-Hib-MCV4)”, 1 entry
  • “Meningococcal Group ACYW135 (Conjugate) (MCV4)”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.